- Report
- July 2019
- 250 Pages
Italy
From €2224EUR$2,300USD£1,910GBP
- Report
- July 2019
- 250 Pages
Germany
From €2224EUR$2,300USD£1,910GBP
- Book
- November 2013
- 982 Pages
- Report
- February 2024
- 185 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- September 2019
Global
From €5192EUR$5,370USD£4,459GBP
- Book
- November 2023
- 336 Pages
- Book
- November 2022
- 176 Pages
- Book
- January 2017
- 576 Pages
- Book
- July 2014
- 224 Pages
- Book
- September 2013
- 352 Pages
- Book
- June 2012
- 144 Pages
- Book
- April 2010
- 754 Pages
- Book
- January 2008
- 460 Pages
The HIV market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs, vaccines, and other treatments to prevent and manage the virus. Research is also conducted to understand the underlying mechanisms of HIV and its effects on the immune system. Additionally, the market includes the development of diagnostics and tests to detect the virus and monitor its progression.
The HIV market is highly competitive, with many companies involved in the development of treatments and therapies. These include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare. Other companies involved in the market include AbbVie, Janssen, and Pfizer. Show Less Read more
